Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Investigating the functions of a neural-specific splicing regulator in the developing and adult mammalian central nervous system.

FY 2010-11

Summary
Most mammalian genes comprise numerous exons which must be correctly spliced in mRNA to produce a functional protein. Certain exons can be included or skipped to result in different protein products from a single gene. This phenomenon is known as alternative splicing (AS) and it is precisely controlled by splicing regulators. The neural-specific Ser/Arg-repeat protein of 100 kDa (nSR100) is a splicing regulator that is specifically expressed in the nervous system of vertebrates. Although we know that nSR100 is required for the production of mature neurons, its exact function in the mammalian nervous system remains unclear. We think that nSR100 acts as a key factor in driving the differentiation of neurons during embryogenesis and neurogenesis in the mature central nervous system of mammals. We will create mouse lines in which inactivation of nSR100 will be targeted to specific regions in the brain of adults or embryos. We will evaluate the development of the central nervous system and neurogenesis using microscopy on brain sections. We will also assess learning and memory by comparing the performance of mutant and wild type mice in behavioral tests. High-throughput sequencing on brain tissues from these animals will be performed to survey the role of nSR100 in the control of AS in the nervous system. Many nSR100-regulated exons known in mammals are conserved in the zebrafish. In complementary studies, the knockdown of these conserved events combined with live imaging in the zebrafish will unveil the cellular mechanisms underlying the neuronal differentiation program controlled by nSR100. Since nSR100 has also been demonstrated to direct AS in genes involved in neurological illnesses such as the Alzheimer disease, our understanding of its contribution to neurogenesis may help reveal mechanisms leading to these diseases and open new therapeutic approaches for neurodegenerative disorders.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
229622
Name
Quesnel-Vallières Mathieu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the functions of a neural-specific splicing regulator in the developing and adult mammalian central nervous system.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Alternative Splicing; Behavioral Tests; Cellular Differentiation; Central Nervous System; Conditional Gene Knockout; Electrophysiology; Immunostaining; Morpholino Oligonucleotide Gene Knockdown; Neurogenesis; Nsr100
Abstract
Most mammalian genes comprise numerous exons which must be correctly spliced in mRNA to produce a functional protein. Certain exons can be included or skipped to result in different protein products from a single gene. This phenomenon is known as alternative splicing (AS) and it is precisely controlled by splicing regulators. The neural-specific Ser/Arg-repeat protein of 100 kDa (nSR100) is a splicing regulator that is specifically expressed in the nervous system of vertebrates. Although we know that nSR100 is required for the production of mature neurons, its exact function in the mammalian nervous system remains unclear. We think that nSR100 acts as a key factor in driving the differentiation of neurons during embryogenesis and neurogenesis in the mature central nervous system of mammals. We will create mouse lines in which inactivation of nSR100 will be targeted to specific regions in the brain of adults or embryos. We will evaluate the development of the central nervous system and neurogenesis using microscopy on brain sections. We will also assess learning and memory by comparing the performance of mutant and wild type mice in behavioral tests. High-throughput sequencing on brain tissues from these animals will be performed to survey the role of nSR100 in the control of AS in the nervous system. Many nSR100-regulated exons known in mammals are conserved in the zebrafish. In complementary studies, the knockdown of these conserved events combined with live imaging in the zebrafish will unveil the cellular mechanisms underlying the neuronal differentiation program controlled by nSR100. Since nSR100 has also been demonstrated to direct AS in genes involved in neurological illnesses such as the Alzheimer disease, our understanding of its contribution to neurogenesis may help reveal mechanisms leading to these diseases and open new therapeutic approaches for neurodegenerative disorders.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Quesnel-Vallières, Mathieu
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~